Correlation Between Cardio Diagnostics and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Checkpoint Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Checkpoint Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Checkpoint Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cardio and Checkpoint is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Checkpoint Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics is expected to generate 2.31 times less return on investment than Checkpoint Therapeutics. In addition to that, Cardio Diagnostics is 2.25 times more volatile than Checkpoint Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 183.00 in Checkpoint Therapeutics on September 12, 2024 and sell it today you would earn a total of 210.00 from holding Checkpoint Therapeutics or generate 114.75% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Cardio Diagnostics |
| Checkpoint Therapeutics |
Cardio Diagnostics and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Checkpoint Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Checkpoint Therapeutics vs. Equillium | Checkpoint Therapeutics vs. DiaMedica Therapeutics | Checkpoint Therapeutics vs. Valneva SE ADR | Checkpoint Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |